Literature DB >> 28148592

Post-malaria neurological syndromes.

Elizabeth A Ashley1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28148592      PMCID： PMC6297603          DOI： 10.7861/clinmedicine.17-1-95

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  5 in total

Review 1.  Exchange transfusion for severe malaria: evidence base and literature review.

Authors:  Kathrine R Tan; Ryan E Wiegand; Paul M Arguin
Journal:  Clin Infect Dis       Date:  2013-06-24       Impact factor: 9.079

2.  Lesson of the month 1: Post-malaria neurological syndromes.

Authors:  Michael D O'Brien; Tania Jagathesan
Journal:  Clin Med (Lond)       Date:  2016-06       Impact factor: 2.659

3.  Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.

Authors:  Arjen Dondorp; François Nosten; Kasia Stepniewska; Nick Day; Nick White
Journal:  Lancet       Date:  2005 Aug 27-Sep 2       Impact factor: 79.321

4.  Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.

Authors:  Arjen M Dondorp; Caterina I Fanello; Ilse C E Hendriksen; Ermelinda Gomes; Amir Seni; Kajal D Chhaganlal; Kalifa Bojang; Rasaq Olaosebikan; Nkechinyere Anunobi; Kathryn Maitland; Esther Kivaya; Tsiri Agbenyega; Samuel Blay Nguah; Jennifer Evans; Samwel Gesase; Catherine Kahabuka; George Mtove; Behzad Nadjm; Jacqueline Deen; Juliet Mwanga-Amumpaire; Margaret Nansumba; Corine Karema; Noella Umulisa; Aline Uwimana; Olugbenga A Mokuolu; Olanrewaju T Adedoyin; Wahab B R Johnson; Antoinette K Tshefu; Marie A Onyamboko; Tharisara Sakulthaew; Wirichada Pan Ngum; Kamolrat Silamut; Kasia Stepniewska; Charles J Woodrow; Delia Bethell; Bridget Wills; Martina Oneko; Tim E Peto; Lorenz von Seidlein; Nicholas P J Day; Nicholas J White
Journal:  Lancet       Date:  2010-11-07       Impact factor: 79.321

5.  UK malaria treatment guidelines 2016.

Authors:  David G Lalloo; Delane Shingadia; David J Bell; Nicholas J Beeching; Christopher J M Whitty; Peter L Chiodini
Journal:  J Infect       Date:  2016-02-12       Impact factor: 6.072
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.